<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reviewed the management and outcome of severe acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in 36 patients younger than 18 years old between March 1977 and June 1987 </plain></SENT>
<SENT sid="1" pm="."><plain>In most patients, no cause could be found </plain></SENT>
<SENT sid="2" pm="."><plain>The best therapeutic results were achieved with allogeneic bone marrow transplantation from histocompatible related donors (14 patients), with a cure rate of 79% </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow transplantation from mismatched related donors was attempted in two patients and failed in both </plain></SENT>
<SENT sid="4" pm="."><plain>Immunosuppression using antithymocyte globulin and/or high-dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> represented an alternative treatment in the absence of a suitable bone marrow donor (12 patients) and induced complete remission in 25% of the patients </plain></SENT>
<SENT sid="5" pm="."><plain>Children treated with supportive care only (eight patients) had a 75% mortality with a very short survival time </plain></SENT>
<SENT sid="6" pm="."><plain>These data confirm the superiority of allogeneic bone marrow transplantation over immunosuppressive therapy in children with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>